Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (31-40 of 547) with videos related to

Pageof 55
Sort By:
CNS Drugs|June 24, 2017
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's DiseaseEva Schaeffer, Daniela Berg
The Lancet. Neurology|April 14, 2023
α-synuclein seed amplification and its uses in Parkinson's diseaseDaniela Berg, Christine Klein
Journal of Inherited Metabolic Disease|June 5, 2014
The significance of GBA for Parkinson's diseaseKathrin Brockmann, Daniela Berg
International Review of Neurobiology|November 30, 2019
'Atypical' Parkinson's disease - sporadicKirsten E Zeuner, Daniela Berg
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2019
Prodromal Parkinson's Disease: The Decade Past, the Decade to ComeRonald B Postuma, Daniela Berg
International Review of Neurobiology|May 31, 2017
The New Diagnostic Criteria for Parkinson's DiseaseRonald B Postuma, Daniela Berg
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2016
Diagnosis of Parkinson's disease: Imaging and geneticsDaniela Berg, Ronald B Postuma
Journal of Parkinson'S Disease|December 26, 2018
From Prodromal to Overt Parkinson's Disease: Towards a New Definition in the Year 2040Daniela Berg, Ronald B Postuma
Nature Reviews. Neurology|October 28, 2016
Advances in markers of prodromal Parkinson diseaseRonald B Postuma, Daniela Berg
Frontiers in Neurology|January 10, 2017
"Cueing" for Levodopa-Induced Dyskinesias in Parkinson's DiseaseEva Schaeffer, Gerd Linke, Daniela Berg
Pageof 55

Showing results (31-40 of 547) with videos related to

Sort By:
Pageof 55
CNS Drugs|June 24, 2017
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's DiseaseEva Schaeffer, Daniela Berg
The Lancet. Neurology|April 14, 2023
α-synuclein seed amplification and its uses in Parkinson's diseaseDaniela Berg, Christine Klein
Journal of Inherited Metabolic Disease|June 5, 2014
The significance of GBA for Parkinson's diseaseKathrin Brockmann, Daniela Berg
International Review of Neurobiology|November 30, 2019
'Atypical' Parkinson's disease - sporadicKirsten E Zeuner, Daniela Berg
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2019
Prodromal Parkinson's Disease: The Decade Past, the Decade to ComeRonald B Postuma, Daniela Berg
International Review of Neurobiology|May 31, 2017
The New Diagnostic Criteria for Parkinson's DiseaseRonald B Postuma, Daniela Berg
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2016
Diagnosis of Parkinson's disease: Imaging and geneticsDaniela Berg, Ronald B Postuma
Journal of Parkinson'S Disease|December 26, 2018
From Prodromal to Overt Parkinson's Disease: Towards a New Definition in the Year 2040Daniela Berg, Ronald B Postuma
Nature Reviews. Neurology|October 28, 2016
Advances in markers of prodromal Parkinson diseaseRonald B Postuma, Daniela Berg
Frontiers in Neurology|January 10, 2017
"Cueing" for Levodopa-Induced Dyskinesias in Parkinson's DiseaseEva Schaeffer, Gerd Linke, Daniela Berg
Pageof 55